HELSINKI — Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed cataract suggested good safety, high tolerability and reversibility for the implant.At the European Society of Cataract and Refractive Surgeons winter meeting, Pavel Stodulka, MD, PhD, presented a video of this procedure, which he said was … [Read more...] about Corneal microlens easy to explant for cataract surgery
News
For third time, FDA does not approve reproxalap for dry eye
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press release from Aldeyra Therapeutics.According to Aldeyra, a complete response letter from the FDA said there was “a lack of substantial evidence” for reproxalap’s efficacy and … [Read more...] about For third time, FDA does not approve reproxalap for dry eye
A Case Series Reveals Features and Outcomes of Ballpoint Pen–Related Penetrating Injuries
A systematic literature review was conducted to compile a case series focusing on trauma with a ballpoint pen that involved both transorbital and intracranial injury. … [Read more...] about A Case Series Reveals Features and Outcomes of Ballpoint Pen–Related Penetrating Injuries
Patients with GA require careful screening, opportunity for treatment
Read this issue’s cover story titled “Specialists navigate changing, challenging landscape of geographic atrophy management.”More knowledge about the diagnosis and management of geographic atrophy is important for every eye doctor.We now have two FDA-approved drugs using intravitreal injection of complement inhibitors, Syfovre (pegcetacoplan injection, Apellis) and Izervay … [Read more...] about Patients with GA require careful screening, opportunity for treatment
VIDEO: ‘Dramatic breakthroughs’ expected in neurotrophic keratitis
WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Francis W. Price Jr., MD, of Price Vision Group, discusses the latest in neurotrophic keratitis.Price said pharmaceuticals are under study for neurotrophic keratitis, nonhealing epithelial defects and limbal stem cell deficiency. There are also new forms of amniotic membrane.“We’re on the verge of some pretty … [Read more...] about VIDEO: ‘Dramatic breakthroughs’ expected in neurotrophic keratitis